123 related articles for article (PubMed ID: 27742266)
21. Comparative two-dimensional polyacrylamide gel electrophoresis of the salivary proteome of children with autism spectrum disorder.
Ngounou Wetie AG; Wormwood KL; Charette L; Ryan JP; Woods AG; Darie CC
J Cell Mol Med; 2015 Nov; 19(11):2664-78. PubMed ID: 26290361
[TBL] [Abstract][Full Text] [Related]
22. Two-Dimensional Polyacrylamide Gel Electrophoresis Coupled with Nanoliquid Chromatography-Tandem Mass Spectrometry-Based Identification of Differentially Expressed Proteins and Tumorigenic Pathways in the MCF7 Breast Cancer Cell Line Transfected for Jumping Translocation Breakpoint Protein Overexpression.
Jayathirtha M; Jayaweera T; Whitham D; Petre BA; Neagu AN; Darie CC
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834160
[TBL] [Abstract][Full Text] [Related]
23. Mucopolysaccharidosis type V. (Scheie syndrome). A postmortem study by multidisciplinary techniques with emphasis on the brain.
Dekaban AS; Constantopoulos G; Herman MM; Steusing JK
Arch Pathol Lab Med; 1976 May; 100(5):237-45. PubMed ID: 817693
[TBL] [Abstract][Full Text] [Related]
24. Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice.
Baldo G; Mayer FQ; Martinelli BZ; de Carvalho TG; Meyer FS; de Oliveira PG; Meurer L; Tavares A; Matte U; Giugliani R
Mol Genet Metab; 2013 May; 109(1):33-40. PubMed ID: 23562162
[TBL] [Abstract][Full Text] [Related]
25. Mucopolysaccharidosis type I.
Wraith JE; Jones S
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
[TBL] [Abstract][Full Text] [Related]
26. Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice.
Watson G; Bastacky J; Belichenko P; Buddhikot M; Jungles S; Vellard M; Mobley WC; Kakkis E
Gene Ther; 2006 Jun; 13(11):917-25. PubMed ID: 16482204
[TBL] [Abstract][Full Text] [Related]
27. Altered interaction and distribution of glycosaminoglycans and growth factors in mucopolysaccharidosis type I bone disease.
Kingma SDK; Wagemans T; IJlst L; Bronckers ALJJ; van Kuppevelt TH; Everts V; Wijburg FA; van Vlies N
Bone; 2016 Jul; 88():92-100. PubMed ID: 27105565
[TBL] [Abstract][Full Text] [Related]
28. Identification of two-dimensionally separated human cerebrospinal fluid proteins by N-terminal sequencing, matrix-assisted laser desorption/ionization--mass spectrometry, nanoliquid chromatography-electrospray ionization-time of flight-mass spectrometry, and tandem mass spectrometry.
Raymackers J; Daniels A; De Brabandere V; Missiaen C; Dauwe M; Verhaert P; Vanmechelen E; Meheus L
Electrophoresis; 2000 Jun; 21(11):2266-83. PubMed ID: 10892737
[TBL] [Abstract][Full Text] [Related]
29. Four novel mutations underlying mild or intermediate forms of alpha-L-iduronidase deficiency (MPS IS and MPS IH/S).
Tieu PT; Bach G; Matynia A; Hwang M; Neufeld EF
Hum Mutat; 1995; 6(1):55-9. PubMed ID: 7550232
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of microRNAs from miR-17 family in the cerebellum of mucopolysaccharidosis type I mice.
Pereira VG; Queiroz MT; D'Almeida V
Gene; 2016 Dec; 595(2):207-211. PubMed ID: 27720939
[TBL] [Abstract][Full Text] [Related]
31. Cloud-point extraction and delipidation of porcine brain proteins in combination with bottom-up mass spectrometry approaches for proteome analysis.
Shevchenko G; Sjödin MO; Malmström D; Wetterhall M; Bergquist J
J Proteome Res; 2010 Aug; 9(8):3903-11. PubMed ID: 20586484
[TBL] [Abstract][Full Text] [Related]
32. Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry.
Vanrobaeys F; Van Coster R; Dhondt G; Devreese B; Van Beeumen J
J Proteome Res; 2005; 4(6):2283-93. PubMed ID: 16335977
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats.
He X; Li CM; Simonaro CM; Wan Q; Haskins ME; Desnick RJ; Schuchman EH
Mol Genet Metab; 1999 Jun; 67(2):106-12. PubMed ID: 10356309
[TBL] [Abstract][Full Text] [Related]
34. Impaired ion homeostasis as a possible associate factor in mucopolysaccharidosis pathogenesis: transcriptomic, cellular and animal studies.
Gaffke L; Szczudło Z; Podlacha M; Cyske Z; Rintz E; Mantej J; Krzelowska K; Węgrzyn G; Pierzynowska K
Metab Brain Dis; 2022 Feb; 37(2):299-310. PubMed ID: 34928474
[TBL] [Abstract][Full Text] [Related]
35. Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice.
Chung S; Ma X; Liu Y; Lee D; Tittiger M; Ponder KP
Mol Genet Metab; 2007 Feb; 90(2):181-92. PubMed ID: 16979922
[TBL] [Abstract][Full Text] [Related]
36. Neuroinflammatory and oxidative stress phenomena in MPS IIIA mouse model: the positive effect of long-term aspirin treatment.
Arfi A; Richard M; Gandolphe C; Bonnefont-Rousselot D; Thérond P; Scherman D
Mol Genet Metab; 2011 May; 103(1):18-25. PubMed ID: 21353610
[TBL] [Abstract][Full Text] [Related]
37. Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector.
Kobayashi H; Carbonaro D; Pepper K; Petersen D; Ge S; Jackson H; Shimada H; Moats R; Kohn DB
Mol Ther; 2005 May; 11(5):776-89. PubMed ID: 15851016
[TBL] [Abstract][Full Text] [Related]
38. Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications.
Scott HS; Bunge S; Gal A; Clarke LA; Morris CP; Hopwood JJ
Hum Mutat; 1995; 6(4):288-302. PubMed ID: 8680403
[TBL] [Abstract][Full Text] [Related]
39. In-depth proteomic profiling of the normal human kidney glomerulus using two-dimensional protein prefractionation in combination with liquid chromatography-tandem mass spectrometry.
Miyamoto M; Yoshida Y; Taguchi I; Nagasaka Y; Tasaki M; Zhang Y; Xu B; Nameta M; Sezaki H; Cuellar LM; Osawa T; Morishita H; Sekiyama S; Yaoita E; Kimura K; Yamamoto T
J Proteome Res; 2007 Sep; 6(9):3680-90. PubMed ID: 17711322
[TBL] [Abstract][Full Text] [Related]
40. Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene.
Hartung SD; Frandsen JL; Pan D; Koniar BL; Graupman P; Gunther R; Low WC; Whitley CB; McIvor RS
Mol Ther; 2004 Jun; 9(6):866-75. PubMed ID: 15194053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
